The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro.

M. G. Murphy, J. Mailhot, J. Borke, J. Wataha, Mohamed M.H. Sharawy, A. Smith

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Certain cells of the periodontium are necessary for the regeneration of tissues that are destroyed as a result of periodontal disease. There has been debate regarding which cells are the primary participants in periodontal regeneration. It is a well-known fact that osteoblasts are essential in new bone formation, but controversy surrounds the role that gingival fibroblasts may play in the regeneration of the hard tissues of the periodontium. If gingival fibroblasts could contribute to the regeneration of these tissues, they might provide an additional source of progenitor cells. The bone morphogenetic proteins are potent stimulators of cell differentiation and have been shown to induce new bone formation in many experimental models. This project investigated the ability of recombinant human bone morphogenetic protein-2 (rhBMP-2) to (1) enhance the production of markers of osteoblastlike cells (osteocalcin and mineralization in culture) in human osteosarcoma cells (MG63) and to (2) induce the expression of an osteoblast phenotype in cultured human gingival fibroblasts (HGFs). MG63 cells and pooled HGFs were exposed to varying concentrations of rhBMP-2 for 24, 48, and 72 hours after 9 days in culture, and osteocalcin levels were measured by enzyme immunosorbent assay in the cell supernatants. In addition, the cells were exposed to rhBMP-2 for 72 hours after 18 days in culture, and mineralization was determined by the Von Kossa stain. The rhBMP-2 had an inhibitory effect on both osteocalcin production and mineralization (p < 0.05) in MG63 cells compared with untreated controls. In addition, increasing doses of rhBMP-2 inhibited both osteocalcin and mineralization in HGF cells. These results suggest that HGFs can express an osteoblastic phenotype when exposed to rhBMP-2; however, rhBMP-2 has inhibitory effects at higher rhBMP-2 doses in both cell types and may, in fact, be inhibitory to MG63 cells.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalThe Journal of oral implantology
Volume27
Issue number1
DOIs
StatePublished - Jan 1 2001

Fingerprint

Osteosarcoma
Fibroblasts
Osteocalcin
Regeneration
Periodontium
Osteoblasts
Osteogenesis
recombinant human bone morphogenetic protein-2
In Vitro Techniques
Phenotype
Immunosorbents
Bone Morphogenetic Proteins
Enzyme Assays
Periodontal Diseases
Cell Differentiation
Theoretical Models
Coloring Agents
Stem Cells

ASJC Scopus subject areas

  • Oral Surgery

Cite this

The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro. / Murphy, M. G.; Mailhot, J.; Borke, J.; Wataha, J.; Sharawy, Mohamed M.H.; Smith, A.

In: The Journal of oral implantology, Vol. 27, No. 1, 01.01.2001, p. 16-24.

Research output: Contribution to journalArticle

Murphy, M. G. ; Mailhot, J. ; Borke, J. ; Wataha, J. ; Sharawy, Mohamed M.H. ; Smith, A. / The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro. In: The Journal of oral implantology. 2001 ; Vol. 27, No. 1. pp. 16-24.
@article{3ecbcf8895d34a2fa932362097c09d32,
title = "The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro.",
abstract = "Certain cells of the periodontium are necessary for the regeneration of tissues that are destroyed as a result of periodontal disease. There has been debate regarding which cells are the primary participants in periodontal regeneration. It is a well-known fact that osteoblasts are essential in new bone formation, but controversy surrounds the role that gingival fibroblasts may play in the regeneration of the hard tissues of the periodontium. If gingival fibroblasts could contribute to the regeneration of these tissues, they might provide an additional source of progenitor cells. The bone morphogenetic proteins are potent stimulators of cell differentiation and have been shown to induce new bone formation in many experimental models. This project investigated the ability of recombinant human bone morphogenetic protein-2 (rhBMP-2) to (1) enhance the production of markers of osteoblastlike cells (osteocalcin and mineralization in culture) in human osteosarcoma cells (MG63) and to (2) induce the expression of an osteoblast phenotype in cultured human gingival fibroblasts (HGFs). MG63 cells and pooled HGFs were exposed to varying concentrations of rhBMP-2 for 24, 48, and 72 hours after 9 days in culture, and osteocalcin levels were measured by enzyme immunosorbent assay in the cell supernatants. In addition, the cells were exposed to rhBMP-2 for 72 hours after 18 days in culture, and mineralization was determined by the Von Kossa stain. The rhBMP-2 had an inhibitory effect on both osteocalcin production and mineralization (p < 0.05) in MG63 cells compared with untreated controls. In addition, increasing doses of rhBMP-2 inhibited both osteocalcin and mineralization in HGF cells. These results suggest that HGFs can express an osteoblastic phenotype when exposed to rhBMP-2; however, rhBMP-2 has inhibitory effects at higher rhBMP-2 doses in both cell types and may, in fact, be inhibitory to MG63 cells.",
author = "Murphy, {M. G.} and J. Mailhot and J. Borke and J. Wataha and Sharawy, {Mohamed M.H.} and A. Smith",
year = "2001",
month = "1",
day = "1",
doi = "10.1563/1548-1336(2001)027<0016:TEOROH>2.3.CO;2",
language = "English (US)",
volume = "27",
pages = "16--24",
journal = "Journal of Oral Implantology",
issn = "0160-6972",
publisher = "Allen Press Inc.",
number = "1",

}

TY - JOUR

T1 - The effects of rhBMP-2 on human osteosarcoma cells and human gingival fibroblasts in vitro.

AU - Murphy, M. G.

AU - Mailhot, J.

AU - Borke, J.

AU - Wataha, J.

AU - Sharawy, Mohamed M.H.

AU - Smith, A.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Certain cells of the periodontium are necessary for the regeneration of tissues that are destroyed as a result of periodontal disease. There has been debate regarding which cells are the primary participants in periodontal regeneration. It is a well-known fact that osteoblasts are essential in new bone formation, but controversy surrounds the role that gingival fibroblasts may play in the regeneration of the hard tissues of the periodontium. If gingival fibroblasts could contribute to the regeneration of these tissues, they might provide an additional source of progenitor cells. The bone morphogenetic proteins are potent stimulators of cell differentiation and have been shown to induce new bone formation in many experimental models. This project investigated the ability of recombinant human bone morphogenetic protein-2 (rhBMP-2) to (1) enhance the production of markers of osteoblastlike cells (osteocalcin and mineralization in culture) in human osteosarcoma cells (MG63) and to (2) induce the expression of an osteoblast phenotype in cultured human gingival fibroblasts (HGFs). MG63 cells and pooled HGFs were exposed to varying concentrations of rhBMP-2 for 24, 48, and 72 hours after 9 days in culture, and osteocalcin levels were measured by enzyme immunosorbent assay in the cell supernatants. In addition, the cells were exposed to rhBMP-2 for 72 hours after 18 days in culture, and mineralization was determined by the Von Kossa stain. The rhBMP-2 had an inhibitory effect on both osteocalcin production and mineralization (p < 0.05) in MG63 cells compared with untreated controls. In addition, increasing doses of rhBMP-2 inhibited both osteocalcin and mineralization in HGF cells. These results suggest that HGFs can express an osteoblastic phenotype when exposed to rhBMP-2; however, rhBMP-2 has inhibitory effects at higher rhBMP-2 doses in both cell types and may, in fact, be inhibitory to MG63 cells.

AB - Certain cells of the periodontium are necessary for the regeneration of tissues that are destroyed as a result of periodontal disease. There has been debate regarding which cells are the primary participants in periodontal regeneration. It is a well-known fact that osteoblasts are essential in new bone formation, but controversy surrounds the role that gingival fibroblasts may play in the regeneration of the hard tissues of the periodontium. If gingival fibroblasts could contribute to the regeneration of these tissues, they might provide an additional source of progenitor cells. The bone morphogenetic proteins are potent stimulators of cell differentiation and have been shown to induce new bone formation in many experimental models. This project investigated the ability of recombinant human bone morphogenetic protein-2 (rhBMP-2) to (1) enhance the production of markers of osteoblastlike cells (osteocalcin and mineralization in culture) in human osteosarcoma cells (MG63) and to (2) induce the expression of an osteoblast phenotype in cultured human gingival fibroblasts (HGFs). MG63 cells and pooled HGFs were exposed to varying concentrations of rhBMP-2 for 24, 48, and 72 hours after 9 days in culture, and osteocalcin levels were measured by enzyme immunosorbent assay in the cell supernatants. In addition, the cells were exposed to rhBMP-2 for 72 hours after 18 days in culture, and mineralization was determined by the Von Kossa stain. The rhBMP-2 had an inhibitory effect on both osteocalcin production and mineralization (p < 0.05) in MG63 cells compared with untreated controls. In addition, increasing doses of rhBMP-2 inhibited both osteocalcin and mineralization in HGF cells. These results suggest that HGFs can express an osteoblastic phenotype when exposed to rhBMP-2; however, rhBMP-2 has inhibitory effects at higher rhBMP-2 doses in both cell types and may, in fact, be inhibitory to MG63 cells.

UR - http://www.scopus.com/inward/record.url?scp=0035222507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035222507&partnerID=8YFLogxK

U2 - 10.1563/1548-1336(2001)027<0016:TEOROH>2.3.CO;2

DO - 10.1563/1548-1336(2001)027<0016:TEOROH>2.3.CO;2

M3 - Article

VL - 27

SP - 16

EP - 24

JO - Journal of Oral Implantology

JF - Journal of Oral Implantology

SN - 0160-6972

IS - 1

ER -